Amylyx Pharmaceuticals, Inc.AMLXNASDAQ
Loading
EBITDA as a percentage of revenue
Latest
0.00%
↑ 100% vs avg
Percentile
P50
Within normal range
Streak
1 yr
Consecutive growthStrong
Average
-1021.23%
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.00% | +100.0% |
| 2024 | -333.03% | -3279.1% |
| 2023 | 10.48% | +101.2% |
| 2022 | -903.53% | - |
| 2021 | 0.00% | +100.0% |
| 2020 | -6000.62% | -7781.2% |
| 2019 | 78.12% | - |